ASXL1 as a critical regulator of epigenetic marks and therapeutic potential of mutated cells

Oncotarget. 2018 Oct 16;9(81):35203-35204. doi: 10.18632/oncotarget.26230.
No abstract available

Keywords: ASXL1; H2AK119Ub; H3K4me3; MDS; OGT.

Publication types

  • Editorial